{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:38:54Z","timestamp":1790138334308,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA154745"],"award-info":[{"award-number":["R01 CA154745"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03 CA223615"],"award-info":[{"award-number":["R03 CA223615"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA225520"],"award-info":[{"award-number":["P30 CA225520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM154635"],"award-info":[{"award-number":["P30 GM154635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007926","name":"University of Oklahoma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024521","name":"Oklahoma Tobacco Settlement Endowment Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015308","name":"Stephenson Cancer Center","doi-asserted-by":"publisher","award":["P30 GM154635"],"award-info":[{"award-number":["P30 GM154635"]}],"id":[{"id":"10.13039\/100015308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015308","name":"Stephenson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA225520"],"award-info":[{"award-number":["P30 CA225520"]}],"id":[{"id":"10.13039\/100015308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canlet.2025.217987","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:34:25Z","timestamp":1754980465000},"page":"217987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anti-tumor activity of CDYL2b in prostate cancer"],"prefix":"10.1016","volume":"632","author":[{"given":"Ruicai","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Janknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4560-0475","authenticated-orcid":false,"given":"Sangphil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Janknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217987_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.217987_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.trecan.2023.06.009","article-title":"Advances in the treatment of metastatic prostate cancer","volume":"9","author":"Gebrael","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.217987_bib3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/cancers15082243","article-title":"Epigenetic modifications in prostate cancer metastasis and microenvironment","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217987_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/cells11071113","article-title":"Histone methylases and demethylases regulating antagonistic methyl marks: changes occurring in cancer","volume":"11","author":"Taylor-Papadimitriou","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2025.217987_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbcan.2019.04.002","article-title":"The small members of the JMJD protein family: enzymatic jewels or jinxes?","volume":"1871","author":"Oh","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217987_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.tibs.2024.06.009","article-title":"Versatile JMJD proteins: juggling histones and much more","volume":"49","author":"Oh","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2025.217987_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.cell.2025.02.023","article-title":"20 years of histone lysine demethylases: from discovery to the clinic and beyond","volume":"188","author":"Gray","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217987_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2006.03.028","article-title":"Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases","volume":"125","author":"Whetstine","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217987_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nature04853","article-title":"The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36","volume":"442","author":"Klose","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217987_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2006.12.147","article-title":"Diversity within the JMJD2 histone demethylase family","volume":"353","author":"Shin","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217987_bib11","doi-asserted-by":"crossref","first-page":"41616","DOI":"10.1074\/jbc.M111.283689","article-title":"Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family","volume":"286","author":"Hillringhaus","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.chembiol.2015.08.007","article-title":"KDM4\/JMJD2 histone demethylase inhibitors block prostate tumor growth by suppressing the expression of AR and BMYB-regulated genes","volume":"22","author":"Duan","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI78132","article-title":"Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217987_bib14","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3892\/or.2016.4747","article-title":"ETS transcription factor ERG cooperates with histone demethylase KDM4A","volume":"35","author":"Kim","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib15","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.celrep.2016.08.018","article-title":"KDM4A coactivates E2F1 to regulate the PDK-dependent metabolic switch between mitochondrial oxidation and glycolysis","volume":"16","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2007.05.179","article-title":"Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D","volume":"359","author":"Shin","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217987_bib17","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib18","first-page":"1","article-title":"ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors","volume":"1826","author":"Oh","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2025.217987_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/cancers17101657","article-title":"Oncogenic fusions harboring ETS genes: exploring novel targetable opportunities in prostate cancer","volume":"17","author":"De Cecco","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217987_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1101\/gad.388206","article-title":"Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells","volume":"20","author":"Fodor","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217987_bib21","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1093\/nar\/gkt106","article-title":"The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover","volume":"41","author":"Coffey","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217987_bib22","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1021\/jm500249n","article-title":"KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor","volume":"57","author":"Chu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/jcp.29117","article-title":"Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy","volume":"235","author":"Sha","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217987_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/path.5495","article-title":"Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer","volume":"252","author":"Tang","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217987_bib25","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.7150\/thno.58729","article-title":"Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217987_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114077","article-title":"Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer","volume":"158","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217987_bib27","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.onc.1206185","article-title":"Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1)","volume":"22","author":"Janknecht","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib29","first-page":"10123","article-title":"Upregulation of PSMD10 caused by the JMJD2A histone demethylase","volume":"9","author":"Kim","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217987_bib30","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1074\/jbc.M400036200","article-title":"Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2\/Neu","volume":"279","author":"Goel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib31","doi-asserted-by":"crossref","first-page":"23657","DOI":"10.1074\/jbc.M111.320101","article-title":"Transcription factors ER71\/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis","volume":"287","author":"DiTacchio","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1122238","article-title":"Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7","volume":"13","author":"Sui","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib33","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1038\/s41598-020-65536-6","article-title":"Opposite roles of the JMJD1A interaction partners MDFI and MDFIC in colorectal cancer","volume":"10","author":"Sui","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib34","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1038\/sj.onc.1206847","article-title":"Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor","volume":"22","author":"Goueli","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib35","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1158\/0008-5472.CAN-09-0941","article-title":"Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1\/ETS-related protein 81","volume":"69","author":"Shin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2012.02.115","article-title":"Histone demethylase JMJD5 is essential for embryonic development","volume":"420","author":"Oh","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217987_bib37","doi-asserted-by":"crossref","first-page":"42669","DOI":"10.1074\/jbc.M205501200","article-title":"Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A","volume":"277","author":"Wu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib38","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jcb.24009","article-title":"The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells","volume":"113","author":"Kim","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217987_bib39","article-title":"Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D\/KDM4D","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217987_bib40","first-page":"236","article-title":"Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors","volume":"6","author":"Kim","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2025.217987_bib41","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1038\/s41598-019-44685-3","article-title":"Relationship between ETS transcription factor ETV1 and TGF-beta-regulated SMAD proteins in prostate cancer","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1295613","article-title":"Methylation of the epigenetic JMJD2D protein by SET7\/9 promotes prostate tumorigenesis","volume":"13","author":"Gu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib43","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1158\/0008-5472.CAN-13-0578","article-title":"14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer","volume":"73","author":"Oh","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib44","first-page":"6652","article-title":"A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217987_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jcb.20945","article-title":"Repression of transcription by TSGA\/Jmjd1a, a novel interaction partner of the ETS protein ER71","volume":"99","author":"Knebel","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217987_bib46","doi-asserted-by":"crossref","first-page":"30443","DOI":"10.1074\/jbc.M110.143792","article-title":"Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase","volume":"285","author":"Mooney","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3892\/or.2012.2079","article-title":"ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells","volume":"29","author":"Shin","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib48","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1128\/MCB.20.19.7300-7310.2000","article-title":"Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300","volume":"20","author":"Papoutsopoulou","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib49","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcb.21884","article-title":"Rcl is a novel ETV1\/ER81 target gene upregulated in breast tumors","volume":"105","author":"Shin","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217987_bib50","first-page":"2690","article-title":"The Ewing's sarcoma gene product functions as a transcriptional activator","volume":"61","author":"Rossow","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bi901263m","article-title":"Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential","volume":"49","author":"Mooney","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2025.217987_bib52","first-page":"795","article-title":"Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer","volume":"14","author":"Oh","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2025.217987_bib53","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/sj.onc.1204820","article-title":"HER2\/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1","volume":"20","author":"Bosc","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3892\/ijo.2014.2279","article-title":"Stimulation of beta-catenin and colon cancer cell growth by the KDM4B histone demethylase","volume":"44","author":"Berry","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib55","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/nar\/gkf390","article-title":"Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter","volume":"30","author":"De Haro","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217987_bib56","doi-asserted-by":"crossref","first-page":"44377","DOI":"10.1074\/jbc.M307202200","article-title":"HER2\/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81","volume":"278","author":"Dowdy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164990","article-title":"SET7\/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A","volume":"8","author":"Gu","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2025.217987_bib58","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/hmg\/ddg185","article-title":"The CDY-related gene family: coordinated evolution in copy number, expression profile and protein sequence","volume":"12","author":"Dorus","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53445-2","article-title":"An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib60","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.7150\/thno.43744","article-title":"Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217987_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217987_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217987_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/346191a0","article-title":"The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation","volume":"346","author":"Wasylyk","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217987_bib64","first-page":"771","article-title":"Molecular characterization of the ets-related human transcription factor ER81","volume":"11","author":"Monte","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib65","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1128\/MCB.23.17.6243-6254.2003","article-title":"Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P\/CAF, and HER2\/Neu","volume":"23","author":"Goel","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib66","first-page":"101","article-title":"Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors","volume":"14","author":"Kim","year":"2023","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nm0695-570","article-title":"p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3","volume":"1","author":"Wales","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217987_bib68","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ncb1974","article-title":"KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer","volume":"11","author":"Gumireddy","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib69","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3892\/ijo.2020.5133","article-title":"Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer","volume":"57","author":"Oh","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053323","article-title":"Control of Hes7 expression by Tbx6, the Wnt pathway and the chemical Gsk3 inhibitor LiCl in the mouse segmentation clock","volume":"8","author":"Gonzalez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217987_bib71","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/s41388-022-02273-2","article-title":"STAT5A modulates CDYL2\/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume":"45","author":"Michailidou","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101141","article-title":"CDYL2 epigenetically regulates MIR124 to control NF-kappaB\/STAT3-dependent breast cancer cell plasticity","volume":"23","author":"Siouda","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2025.217987_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00018-022-04659-7","article-title":"Chromodomain on Y-like 2 (CDYL2) implicated in mitosis and genome stability regulation via interaction with CHAMP1 and POGZ","volume":"80","author":"Siouda","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.217987_bib75","first-page":"630","article-title":"MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a\/b-5p-KLF17 axis","volume":"10","author":"Hu","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12032-012-0425-3","article-title":"Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma","volume":"30","author":"Liu","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.canlet.2025.217987_bib77","first-page":"2117","article-title":"Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer","volume":"42","author":"Jiang","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217987_bib78","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1078-0432.CCR-12-2888","article-title":"HIC1 modulates prostate cancer progression by epigenetic modification","volume":"19","author":"Zheng","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217987_bib79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/path.4913","article-title":"HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition","volume":"242","author":"Hao","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217987_bib80","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-022-05086-z","article-title":"Targeting HIC1\/TGF-beta axis-shaped prostate cancer microenvironment restrains its progression","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217987_bib81","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/35624","article-title":"Three neural tubes in mouse embryos with mutations in the T-box gene Tbx6","volume":"391","author":"Chapman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217987_bib82","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddt012","article-title":"Autosomal dominant spondylocostal dysostosis is caused by mutation in TBX6","volume":"22","author":"Sparrow","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib83","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/cge.12918","article-title":"Autosomal recessive variations of TBX6, from congenital scoliosis to spondylocostal dysostosis","volume":"91","author":"Lefebvre","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib84","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1101\/gad.930601","article-title":"Dynamic expression and essential functions of Hes7 in somite segmentation","volume":"15","author":"Bessho","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217987_bib85","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1093\/hmg\/ddn272","article-title":"Mutation of Hairy-and-Enhancer-of-Split-7 in humans causes spondylocostal dysostosis","volume":"17","author":"Sparrow","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib86","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/carcin\/bgu048","article-title":"GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer","volume":"35","author":"Naiki","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2025.217987_bib87","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14263","article-title":"GPX2 predicts recurrence-free survival and triggers the Wnt\/beta-catenin\/EMT pathway in prostate cancer","volume":"10","author":"Yang","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.canlet.2025.217987_bib88","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/s41388-021-02059-y","article-title":"The role of R-spondin proteins in cancer biology","volume":"40","author":"Ter Steege","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217987_bib89","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/jbc.M112.432807","article-title":"Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer","volume":"288","author":"Esser","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.673904","article-title":"Disruption of LTBP4 inhibition-induced TGFbeta1 activation promoted cell proliferation and metastasis in skin melanoma by inhibiting the activation of the Hippo-YAP1 signaling pathway","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib91","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/17501911.2024.2388017","article-title":"Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer","volume":"16","author":"He","year":"2024","journal-title":"Epigenomics"},{"key":"10.1016\/j.canlet.2025.217987_bib92","doi-asserted-by":"crossref","first-page":"19626","DOI":"10.1074\/jbc.M802655200","article-title":"Specificity of the chromodomain Y chromosome family of chromodomains for lysine-methylated ARK(S\/T) motifs","volume":"283","author":"Fischle","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217987_bib93","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chembiol.2020.05.007","article-title":"Structural basis for the binding selectivity of human CDY chromodomains","volume":"27","author":"Dong","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2025.217987_bib94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13072-020-00366-4","article-title":"The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells","volume":"13","author":"Vaughan","year":"2020","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.canlet.2025.217987_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/7771","article-title":"Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome","volume":"21","author":"Lahn","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217987_bib96","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1073\/pnas.082248899","article-title":"Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis","volume":"99","author":"Lahn","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.217987_bib97","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2017.07.011","article-title":"Chromodomain protein CDYL acts as a crotonyl-CoA hydratase to regulate histone crotonylation and spermatogenesis","volume":"67","author":"Liu","year":"2017","journal-title":"Mol. Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525005579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:36:24Z","timestamp":1772804184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":97,"alternative-id":["S0304383525005579"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217987","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumor activity of CDYL2b in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217987"}}